滋肾清热利湿化瘀方通过C/EBPβ/STAT3通路改善多囊卵巢综合征
本研究探讨滋肾清热利湿化瘀方(ZQLHR)对多囊卵巢综合征(PCOS)卵巢颗粒细胞增殖-凋亡平衡的调节机制。采用PCOS患者颗粒细胞、来曲唑诱导PCOS小鼠及KGN细胞,结合scAAV介导的C/EBPβ敲低与CETSA实验。结果显示ZQLHR通过调控C/EBPβ/STAT3通路改善颗粒细胞稳态并促进卵泡发育。
要点
- PCOS患者颗粒细胞增殖降低、凋亡增加且C/EBPβ/STAT3表达下降。
- ZQLHR改善PCOS小鼠动情周期规律性、激素平衡及卵泡发育。
- CETSA首次证实ZQLHR与C/EBPβ直接结合。
核心结论
- ZQLHR通过调控C/EBPβ/STAT3通路改善PCOS颗粒细胞稳态并促进卵泡发育。
研究设计与样本
- 分析PCOS与非PCOS患者来源的人颗粒细胞(hGCs)的增殖、凋亡及C/EBPβ/STAT3表达。
- 体内采用来曲唑诱导的PCOS小鼠,经scAAV介导C/EBPβ敲低后给予ZQLHR治疗。
- 体外在人颗粒细胞样肿瘤细胞系(KGN)中沉默C/EBPβ或STAT3,并以剂量和时间依赖性方式评估ZQLHR效应。
- 采用CETSA确认ZQLHR与C/EBPβ的直接结合,并对C/EBPβ沉默细胞给予ZQLHR以检验其效应是否涉及C/EBPβ依赖性STAT3。
主要发现
- PCOS患者来源颗粒细胞表现为增殖降低、凋亡升高及C/EBPβ/STAT3表达下降。
- LET诱导PCOS小鼠中,ZQLHR治疗显著改善动情周期规律性、激素平衡、卵泡发育及颗粒细胞凋亡,并伴随C/EBPβ/STAT3通路调节。
- C/EBPβ敲低加重卵巢功能障碍和KGN细胞凋亡,而ZQLHR减轻这些效应并部分恢复通路活性。
- 体外C/EBPβ与STAT3相互影响并影响CFTR表达,与增殖和凋亡变化相关。
- ZQLHR以剂量和时间依赖性方式增加增殖标志物(PCNA、cyclin D1)并减少凋亡标志物(Caspase-3、PARP),CETSA证实其与C/EBPβ直接结合;C/EBPβ敲低后ZQLHR仍部分恢复KGN细胞增殖并适度调节C/EBPβ/STAT3通路。
临床怎么用
- ZQLHR在PCOS中通过C/EBPβ/STAT3轴改善颗粒细胞增殖-凋亡平衡,支持其临床用于提高排卵率和月经周期规律性。
- 对C/EBPβ/STAT3通路表达下降的PCOS患者,ZQLHR可能部分恢复通路活性并改善卵泡发育。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder characterized by ovulation disorders. Zishen Qingre Lishi Huayu Recipe (ZQLHR), a traditional Chinese medicine (TCM) formula, has shown clinical efficacy by effectively increasing the ovulation rate and menstrual cycle regularity in patients with PCOS and is widely used in practice; however, its underlying pharmacological mechanism has not been fully elucidated. AIM OF THE STUDY: Aim of the study: This study aimed to elucidate how ZQLHR modulates the proliferation-apoptosis balance of ovarian granulosa cells (GCs) in PCOS via the C/EBPβ/STAT3 signaling axis. METHODS: Human granulosa cells (hGCs) from PCOS and non-PCOS patients were analyzed for proliferation, apoptosis, and C/EBPβ/STAT3 expression. In vivo, letrozole-induced PCOS mice were subjected to scAAV-mediated C/EBPβ knockdown, followed by administration of ZQLHR to evaluate treatment outcomes. In vitro, C/EBPβ or STAT3 was silenced in Human granulosa-like tumor cell line (KGN) cells to explore their regulatory relationship and roles in proliferation and apoptosis. Additionally, ZQLHR effects were evaluated in a dose- and time-dependent manner. Notably, CETSA was employed to confirm for the first time direct binding of ZQLHR to C/EBPβ, and C/EBPβ-silenced cells were subsequently treated with ZQLHR to examine whether its effects involve C/EBPβ-dependent STAT3. The pharmacological mechanism of ZQLHR was further evaluated through histological and molecular biology experiments. RESULTS: PCOS patient-derived GCs exhibited reduced proliferation, elevated apoptosis, and decreased C/EBPβ/STAT3 expression. In LET-induced PCOS mice, ZQLHR treatment significantly improved estrous cycle regularity, hormonal balance, follicular development, and GC apoptosis, accompanied by modulation of the C/EBPβ/STAT3 pathway. C/EBPβ knockdown exacerbated ovarian dysfunction and KGN apoptosis, whereas ZQLHR attenuated these effects and partially restored pathway activity. In vitro, C/EBPβ and STAT3 influenced each other and CFTR expression, associated with changes in proliferation and apoptosis. ZQLHR increased proliferation markers (PCNA, cyclin D1) and decreased apoptosis markers (Caspase-3, PARP) in a dose- and time-dependent manner, with CETSA confirming direct binding to C/EBPβ. Notably, despite C/EBPβ knockdown, ZQLHR partially restored KGN cell proliferation and modestly modulated the C/EBPβ/STAT3 signaling pathway. CONCLUSION: ZQLHR improves GC homeostasis and promotes follicular development in PCOS by modulating the C/EBPβ/STAT3 pathway.
引用
- Jin J, Li P, Yu X, et al. Zishen Qingre Lishi Huayu recipe improves polycystic ovary syndrome by restoring granulosa cell homeostasis via C/EBPβ/STAT3 signaling. J Ethnopharmacol. 2026. PMID: 42288165. doi:10.1016/j.jep.2026.122019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。